Publications by authors named "A Ryding"
Background: Aortic conduit and reservoir functions can be directly measured by four-dimensional flow (4D flow) cardiovascular magnetic resonance (CMR).
Methods: Twenty healthy controls (10 young and 10 age-gender-matched old controls) and 20 patients with heart failure with preserved ejection fraction (HFpEF) were recruited. All had 4D flow CMR.
Background: Impaired endogenous fibrinolysis is adverse cardiovascular risk factor in acute coronary syndrome (ACS) patients. Addition of very low dose rivaroxaban (VLDR) to dual antiplatelet therapy (DAPT) reduces cardiovascular events but increases bleeding.
Objective: We aimed to assess whether addition of VLDR to DAPT can enhance endogenous fibrinolysis.
Article Synopsis
- The study investigates how monocyte subsets change after elective percutaneous coronary intervention (PCI) and their connection to inflammation in heart disease.
- Intermediate monocytes (CD14++CD16+) were found to decrease shortly after PCI, recover in two weeks, and significantly increase at two months, particularly in patients with drug-eluting stents (DES).
- Additionally, specific gene expressions and humoral biomarkers showed notable changes, with some remaining elevated for weeks post-procedure, indicating that the type of PCI might influence the inflammatory response.
Aims: We aimed to perform a cost analysis of drug coated balloon (DCB)-only angioplasty versus drug eluting stent (DES), for de novo disease of all vessel sizes and all clinical indications.
Background: DCB angioplasty is an emergent technology for the treatment of coronary artery disease. There is lack of data regarding the cost-effectiveness of DCB-only angioplasty for treatment of de novo coronary artery disease as compared with second generation DES.
Background: Primary percutaneous coronary intervention (pPCI) with drug-eluting stents (DES) has emerged as the standard of care, but stent-related events have persisted. Drug-coated balloon (DCB)-only angioplasty is an emerging technology, although it is not fully evaluated compared with DES in the context of pPCI.
Objectives: The aim of this study was to investigate the safety of DCB-only angioplasty compared with second-generation DES in pPCI.